Fortifai Limited (ASX:FTI)
Australia · Delayed Price · Currency is AUD 0.1450
+0.0050 (3.57%)
At close: Aug 1, 2025, 4:00 PM AEST
Blueprint Medicines Revenue
Fortifai had revenue of 2.54M AUD in the half year ending December 31, 2024, with 1.40% growth. This brings the company's revenue in the last twelve months to 3.91M, down -52.01% year-over-year. In the fiscal year ending June 30, 2024, Fortifai had annual revenue of 5.10M, down -26.39%.
Revenue (ttm)
3.91M
Revenue Growth
-52.01%
P/S Ratio
5.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 5.10M | -1.83M | -26.39% |
| Jun 30, 2023 | 6.93M | 2.03M | 41.56% |
| Jun 30, 2022 | 4.90M | 1.62M | 49.38% |
| Jun 30, 2021 | 3.28M | 742.11K | 29.26% |
| Jun 30, 2020 | 2.54M | 397.69K | 18.60% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Commonwealth Bank of Australia | 26.73B |
| BHP Group | 87.21B |
| CSL Limited | 24.61B |
| National Australia Bank | 20.05B |
| Westpac Banking | 21.37B |
| Wesfarmers | 45.01B |
| ANZ Group Holdings | 21.10B |
| Macquarie Group | 17.32B |